No evidence of blood clot risk in any age group, gender, or batch: AstraZeneca

AstraZeneca on Friday defended its vaccine saying that there was "no evidence of an increased risk" of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed and that rollouts should continue. According to media reports, after a group of European countries -- including Denmark, Norway and Iceland -- suspended the use of the vaccine on Thursday, Thailand's Prime Minister, Prayut Chan-o-cha, canceled plans to publicly get the AstraZeneca shot on Friday and the country also delayed its rollout.

from IndiaTV World: Google News Feed https://ift.tt/3csu6ax